Sigalov AB. Front Oncol. 2025
Category: Publication
Inhibiting Triggering Receptor Expressed on Myeloid Cells 1 Signaling to Ameliorate Skin Fibrosis
Bale et al. JCI Insight. 2024
TREM-1 and TREM-2 as Therapeutic Targets: Clinical Challenges and Perspectives
Sigalov AB. Front Immunol. 2024
Triggering receptor expressed on myeloid cells-1 (TREM-1) contributes to Bordetella pertussis inflammatory pathology
Gallop D, Scanlon K et al. Infect Immun. 2021
SCHOOL of nature: ligand-independent immunomodulatory peptides
Sigalov AB. Drug Discovery Today. 2020
Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice
Tornai D, Furi I et al. Hepatol Commun. 2019
Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes
Pullikuth et al. Front Oncol. 2021
Commentary: Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation
Sigalov AB. Front Immunol. 2020
Targeting Tumor-Associated Macrophages to Radiosensitize Glioblastoma in a Mouse Model
Mark DJ, Ruggieri M et al. Int J Radiat Oncol Biol Phys. 2019
